ミリプラチンを用いたマイクロバルーン閉鎖下肝動脈化学塞栓療法(B-TACE)の初期経験

書誌事項

タイトル別名
  • Balloon-occluded transcatheter arterial chemoembolization using miriplatin for hepatocellular carcinoma
  • ミリプラチン オ モチイタ マイクロバルーン ヘイサ カ カン ドウミャク カガク ソクセン リョウホウ(B-TACE)ノ ショキ ケイケン

この論文をさがす

抄録

The efficacy and safety of balloon-occluded transcatheter arterial chemoembolization (B-TACE) using miriplatin were investigated in 26 patients with hepatocellular carcinoma, and compared with conventional TACE (C-TACE). In the B-TACE group, a treatment effect (TE) of 4 was obtained in 61.5%, TE3 in 34.6%, TE2 in 3.8%, and TE1 in 0%. In the C-TACE group, the respective results were 44.2%, 34.6%, 19.2%, and 1.9%. Efficacy was significantly higher in the B-TACE group. There were no significant differences in the incidence of adverse events of grade 3 or more severe between the two groups. B-TACE using miriplatin is more useful than C-TACE, and B-TACE is as safe as C-TACE.<br>

収録刊行物

  • 肝臓

    肝臓 54 (1), 81-83, 2013

    一般社団法人 日本肝臓学会

被引用文献 (1)*注記

もっと見る

参考文献 (6)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ